Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection

NCT00441246 is registered in ClinicalTrials.gov with Adams Respiratory Therapeutics as lead sponsor.

NCT NCT00441246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00441246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection
Lead sponsor
Adams Respiratory Therapeutics
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2007
Completion date
July 31, 2007
Enrollment
600 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, bronchitis, rhinosinusitis